Abstract
A minimally invasive, highly efficient and versatile strategy is proposed for localized tumor regression by developing a smart injectable liquid-solid phase-transformation organic-inorganic hybrid composite material, i.e., magnetic-Fe-powder-dispersed PLGA (Fe/PLGA) implants for magnetic hyperthermia therapy of cancer.
Keywords:
PLGA; cancer therapy; implant; magnetic ablation; phase transformation.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Ablation Techniques / instrumentation
-
Ablation Techniques / methods
-
Adenocarcinoma / pathology
-
Adenocarcinoma / therapy*
-
Animals
-
Humans
-
Hyperthermia, Induced* / instrumentation
-
Hyperthermia, Induced* / methods
-
Lactic Acid / administration & dosage
-
Lactic Acid / chemistry
-
MCF-7 Cells
-
Magnetic Fields*
-
Magnetite Nanoparticles / administration & dosage*
-
Magnetite Nanoparticles / chemistry
-
Mice, Nude
-
Microscopy, Electron, Transmission
-
Necrosis / pathology
-
Neoplasm Transplantation
-
Phase Transition
-
Polyglycolic Acid / administration & dosage
-
Polyglycolic Acid / chemistry
-
Polylactic Acid-Polyglycolic Acid Copolymer
-
Powders
-
Sodium Chloride / chemistry
-
Temperature
-
Tumor Burden
-
Ultrasonography
Substances
-
Magnetite Nanoparticles
-
Powders
-
Polylactic Acid-Polyglycolic Acid Copolymer
-
Polyglycolic Acid
-
Lactic Acid
-
Sodium Chloride